News

Researchers of the IDIBELL have developed a preclinical therapeutic model to test new treatments for brain metastases in breast cancer patients. The results of the study are published in the International Journal of Molecular Sciences.

In Europe there are about 2 million people with minimal Hepatic Encephalopathy, 200,000 in Spain. Most of them are undiagnosed so that cannot prevent the progression of the disease with cognitive and motor impairment that this entails.

Josep Marco, researcher at the group of Brain Plasticity and Cognition at IDIBELL and the University of Barcelona spoke about brain and mathematics at Centre Cultural Sant Josep of L’Hospitalet de Llobregat (Barcelona), within the cycle Pessics de Ciència.

The IDIBELL researcher Gabriel Capellá has been appointed new Head of Research and Innovation for Health of the Health Department of the Generalitat de Catalunya, replacing Marta Aymerich.